Citation Impact
Citing Papers
Differential Effects of Octreotide and Pasireotide on Somatostatin Receptor Internalization and Trafficking in Vitro
2008
High Penetrance of Pheochromocytoma Associated with the Novel C634Y/Y791F Double Germline Mutation in the RET Protooncogene
2010
Carotenoids: biochemistry, pharmacology and treatment
2016 Standout
Cancer treatment and survivorship statistics, 2022
2022 Standout
Combined effects of radiotherapy and photodynamic therapy on an in vitro human prostate model.
2004
A comprehensive overview of the role of the RET proto-oncogene in thyroid carcinoma
2016
Acromegaly
2006 Standout
HMGA2 expression in white adipose tissue linking cellular senescence with diabetes
2013
Effect of Two Years of Growth Hormone and Insulin-Like Growth Factor-I Suppression on Prostate Diseases in Acromegalic Patients1
2000
Estrogen Receptors: How Do They Signal and What Are Their Targets
2007 Standout
Retinoic acid receptors: From molecular mechanisms to cancer therapy
2014
Estrogen receptors and human disease
2006 Standout
Thyroid cancer
2016 Standout
Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment
2009 Standout
Oncogenic kinase signalling
2001 StandoutNature
Phaeochromocytoma
2005 Standout
Organic Causes of Erectile Dysfunction in Men Under 40
2013 Standout
Melatonin and the pituitary‐thyroid axis status in blind adults: a possible resetting after puberty
1995
RET Germline Mutations Identified by Exome Sequencing in a Chinese Multiple Endocrine Neoplasia Type 2A/Familial Medullary Thyroid Carcinoma Family
2011
WHO-EORTC classification for cutaneous lymphomas
2005 Standout
New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer
2018 Standout
PERSPECTIVE ARTICLE: Growth factors and cytokines in wound healing
2008 Standout
Receptor-targeting mechanisms of pain-causing toxins: How ow?
2012 StandoutNobel
Male acquired hypogonadotropic hypogonadism: Diagnosis and treatment
2012
Dietary phenolics: chemistry, bioavailability and effects on health
2009 Standout
Therapeutic potential of β-arrestin- and G protein-biased agonists
2010 StandoutNobel
Inhibition of Smad3 expression decreases collagen synthesis in keloid disease fibroblasts
2007
Graves' Ophthalmopathy
2010 Standout
Opportunities in somatostatin research: biological, chemical and therapeutic aspects
2003
Pheochromocytoma presenting as shock
1989
Novel germline mutation in the transmembrane region of RET gene close to Cys634Ser mutation associated with MEN 2A syndrome
2004
The effects of lycopene on the proliferation of human breast cells and BRCA1 and BRCA2 gene expression
2004
The RET proto-oncogene in human cancers
2000
Phyto-oestrogens and cancer
2002
Expression Cloning and Characterization of Oxidative 17β- and 3α-Hydroxysteroid Dehydrogenases from Rat and Human Prostate
1997
Scarless Wound Healing
2015
Parkinson's Disease as a Neuroendocrine Disorder of Circadian Function: Dopamine-Melatonin Imbalance and the Visual System in the Genesis and Progression of the Degenerative Process
2008
New hypotheses for the health-protective mechanisms of whole-grain cereals: what is beyond fibre?
2010 Standout
Hypertrophic Scarring and Keloids: Pathomechanisms and Current and Emerging Treatment Strategies
2010 Standout
Bv8/Prokineticin proteins and their receptors
2007
Prostatic Hyperplasia: An Unknown Feature of Acromegaly
1998
Modulation of expression of somatostatin receptor subtypes in Graves’ ophthalmopathy orbits: relevance to novel analogs
2007
Antisperm antibodies in infertile men and their correlation with seminal parameters
2007
A Study of Sexuality and Health among Older Adults in the United States
2007 Standout
Nonsurgical Management of Hypertrophic Scars: Evidence-Based Therapies, Standard Practices, and Emerging Methods
2020
Opposing Action of Estrogen Receptors α and β on Cyclin D1 Gene Expression
2002
VEGF in Signaling and Disease: Beyond Discovery and Development
2019 Standout
Characterization of the RET protooncogene transmembrane domain mutation S649L associated with nonaggressive medullary thyroid carcinoma.
2008
Multiple endocrine neoplasia type 2 and the RET protooncogene: From bedside to bench to bedside
2005
Prophylactic thyroidectomy in multiple endocrine neoplasia: the impact of molecular mechanisms of RET proto-oncogene
2003
Comparative genomic hybridization analysis of primary cutaneous B‐cell lymphomas: Identification of common genomic alterations in disease pathogenesis
2002
Octreotide in the Management of Hormone-Refractory Prostate Cancer
2001
Familial Medullary Thyroid Carcinoma with Noncysteine RET Mutations: Phenotype-Genotype Relationship in a Large Series of Patients
2001
Thyroid Hormones Regulate Selenoprotein Expression and Selenium Status in Mice
2010
The role of estrogens and estrogen receptors in normal prostate growth and disease
2007
A NovelVal648IleSubstitution inRETProtooncogene Observed in aCys634ArgMultiple Endocrine Neoplasia Type 2A Kindred Presenting with an Adrenocorticotropin-Producing Pheochromocytoma
2002
Cellular senescence: from physiology to pathology
2014 Standout
Relative Quantification of Indium-111 Pentetreotide and Gallium-68 DOTATOC Uptake in the Thyroid Gland and Association with Thyroid Pathologies
2009
Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma
2015 Standout
Medullary Thyroid Cancer: Management Guidelines of the American Thyroid Association
2009 Standout
The Role of Selenium in Inflammation and Immunity: From Molecular Mechanisms to Therapeutic Opportunities
2011 Standout
2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum
2017 Standout
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
RET as a Diagnostic and Therapeutic Target in Sporadic and Hereditary Endocrine Tumors
2006
Screening for Thyroid Cancer
2017
Neurobiological Mechanisms of the Onset of Puberty in Primates*
2001
Structure of the STRA6 receptor for retinol uptake
2016 StandoutScienceNobel
Endocrine-Disrupting Chemicals: An Endocrine Society Scientific Statement
2009 Standout
The Senescence-Associated Secretory Phenotype: The Dark Side of Tumor Suppression
2010 Standout
Memory--a Century of Consolidation
2000 StandoutScience
A Toll-Like Receptor 2-Responsive Lipid Effector Pathway Protects Mammals against Skin Infections with Gram-Positive Bacteria
2005 StandoutNobel
Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus
2016 Standout
Screening for Colorectal Cancer
2016 Standout
Systemic Complications of Acromegaly: Epidemiology, Pathogenesis, and Management
2004 Standout
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Characterization of Insulin-Like Growth Factor-Binding Protein-Related Proteins (IGFBP-rPs) 1, 2, and 3 in Human Prostate Epithelial Cells: Potential Roles for IGFBP-rP1 and 2 in Senescence of the Prostatic Epithelium*
2000
Estimation of Risk of Inherited Medullary Thyroid Carcinoma in Apparent Sporadic Patients
2001
Estrogen receptor β regulates epithelial cellular differentiation in the mouse ventral prostate
2004
The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders
2011 Standout
Temporal trends in sperm count: a systematic review and meta-regression analysis of samples collected globally in the 20th and 21st centuries
2022 Standout
Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care
2011 Standout
Wound Healing: A Cellular Perspective
2018 Standout
Cancer treatment and survivorship statistics, 2019
2019 Standout
Signal transduction growth factors: the effective governance of transcription and cellular adhesion in cancer invasion
2017
Identification of a fatty acid Δ6-desaturase deficiency in human skin fibroblasts
2001
The Timing of Normal Puberty and the Age Limits of Sexual Precocity: Variations around the World, Secular Trends, and Changes after Migration
2003 Standout
Extrapineal melatonin: sources, regulation, and potential functions
2014 Standout
The Metabolic Syndrome
2008 Standout
Diabetic Neuropathy: A Position Statement by the American Diabetes Association
2016 Standout
Increased uptake of 111In-octreotide in idiopathic pulmonary fibrosis.
2006
Guidelines for the management of thyroid cancer
2014 Standout
The Prokineticins: Neuromodulators and Mediators of Inflammation and Myeloid Cell-Dependent Angiogenesis
2018
Novel tandem germline RET proto‐oncogene mutations in a patient with multiple endocrine neoplasia type 2B: Report of a case and a literature review of tandem RET mutations with in silico analysis
2013
Nonsurgical Management of Hypertrophic Scars: Evidence-Based Therapies, Standard Practices, and Emerging Methods
2007
Thyroid carcinoma
2003 Standout
Peptide Receptors as Molecular Targets for Cancer Diagnosis and Therapy
2003
Works of Daniela Pasquali being referenced
Changes in Tissue Transglutaminase Activity and Expression during Retinoic Acid-Induced Growth Arrest and Apoptosis in Primary Cultures of Human Epithelial Prostate Cells1
1999
Normal plasma insulin-like growth factor I levels and impaired final stature in adult blind subjects
1994
Verapamil inhibits interleukin-6 and vascular endothelial growth factor production in primary cultures of keloid fibroblasts
2003
Current concepts of pheochromocytoma
2014
Somatostatin Receptor Genes Are Expressed in Lymphocytes from Retroorbital Tissues in Graves’ Disease
2002
Endocrine Secretions under Abnormal Light-Dark Cycles and in the Blind
1998
Somatostatin receptor gene expression and inhibitory effects of octreotide on primary cultures of orbital fibroblasts from Graves' ophthalmopathy
2000
Loss of Estrogen Receptor β Expression in Malignant Human Prostate Cells in Primary Cultures and in Prostate Cancer Tissues1
2001
Retinoic acid receptors alpha, beta and gamma, and cellular retinol binding protein-I expression in breast fibrocystic disease and cancer
1997
Fenofibrate increases the expression of high mobility group AT-hook 2 (HMGA2) gene and induces adipocyte differentiation of orbital fibroblasts from Graves' ophthalmopathy
2004
EPN: A NOVEL EPITHELIAL CELL LINE DERIVED FROM HUMAN PROSTATE TISSUE
2002
Prognostic implications of node metastatic features in OSCC: A retrospective study on 121 neck dissections
2013
Impact of prophylactic central compartment neck dissection on locoregional recurrence of differentiated thyroid cancer in clinically node-negative patients: A retrospective study of a large clinical series
2014
Genetic prenatal RET testing and pregnancy management of multiple endocrine neoplasia Type II A (MEN2A): A case report
2004
Epigenetic fingerprint in endometrial carcinogenesis: The hypothesis of a uterine field cancerization
2011
Consensus statement on diagnosis and clinical management of Klinefelter syndrome
2010
The Endocrine-Gland-Derived Vascular Endothelial Growth Factor (EG-VEGF)/Prokineticin 1 and 2 and Receptor Expression in Human Prostate: Up-Regulation of EG-VEGF/Prokineticin 1 with Malignancy
2006
Loss of Estrogen Receptor Expression in Malignant Human Prostate Cells in Primary Cultures and in Prostate Cancer Tissues
2001
Changes in Tissue Transglutaminase Activity and Expression during Retinoic Acid-Induced Growth Arrest and Apoptosis in Primary Cultures of Human Epithelial Prostate Cells
1999
A Novel Case of Multiple Endocrine Neoplasia Type 2A Associated with Two de Novo Mutations of the RETProtooncogene*
1999
Antipituitary Antibodies against Gonadotropin-Secreting Cells in Adult Male Patients with Apparently Idiopathic Hypogonadotropic Hypogonadism
2006
Abnormal level of retinoic acid in prostate cancer tissues.
1996
Effects of somatostatin analog SOM230 on cell proliferation, apoptosis, and catecholamine levels in cultured pheochromocytoma cells
2008
ANTISPERM ANTIBODIES IN CRYPTORCHIDISM BEFORE AND AFTER SURGERY
1998
Abnormal level of retinoic acid in prostate cancer tissues
1996
Different Expression Patterns of Somatostatin Receptor Subtypes in Cultured Epithelial Cells from Human Normal Prostate and Prostate Cancer1
1997